These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31555275)

  • 1. TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells.
    Tawfik D; Groth C; Gundlach JP; Peipp M; Kabelitz D; Becker T; Oberg HH; Trauzold A; Wesch D
    Front Immunol; 2019; 10():2044. PubMed ID: 31555275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory Interactions Between Neutrophils, Tumor Cells and T Cells.
    Oberg HH; Wesch D; Kalyan S; Kabelitz D
    Front Immunol; 2019; 10():1690. PubMed ID: 31379875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicity.
    Gonnermann D; Oberg HH; Kellner C; Peipp M; Sebens S; Kabelitz D; Wesch D
    Oncoimmunology; 2015 Mar; 4(3):e988460. PubMed ID: 25949900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKG2D regulates production of soluble TRAIL by ex vivo expanded human γδ T cells.
    Dokouhaki P; Schuh NW; Joe B; Allen CA; Der SD; Tsao MS; Zhang L
    Eur J Immunol; 2013 Dec; 43(12):3175-82. PubMed ID: 24019170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celastrol increases osteosarcoma cell lysis by γδ T cells through up-regulation of death receptors.
    Li Z; Zhang J; Tang J; Wang R
    Oncotarget; 2016 Dec; 7(51):84388-84397. PubMed ID: 27768597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel bispecific antibodies increase γδ T-cell cytotoxicity against pancreatic cancer cells.
    Oberg HH; Peipp M; Kellner C; Sebens S; Krause S; Petrick D; Adam-Klages S; Röcken C; Becker T; Vogel I; Weisner D; Freitag-Wolf S; Gramatzki M; Kabelitz D; Wesch D
    Cancer Res; 2014 Mar; 74(5):1349-60. PubMed ID: 24448235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells.
    Jonescheit H; Oberg HH; Gonnermann D; Hermes M; Sulaj V; Peters C; Kabelitz D; Wesch D
    Cells; 2020 May; 9(5):. PubMed ID: 32384638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.
    Alexander AA; Maniar A; Cummings JS; Hebbeler AM; Schulze DH; Gastman BR; Pauza CD; Strome SE; Chapoval AI
    Clin Cancer Res; 2008 Jul; 14(13):4232-40. PubMed ID: 18594005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells.
    Rambow AC; Aschenbach I; Hagelund S; Tawfik D; Gundlach JP; Weiße S; Maass N; Trauzold A
    Front Cell Dev Biol; 2022; 10():942718. PubMed ID: 36158196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor resistance mechanisms and their consequences on γδ T cell activation.
    Wesch D; Kabelitz D; Oberg HH
    Immunol Rev; 2020 Nov; 298(1):84-98. PubMed ID: 33048357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killing of laminin receptor-positive human lung cancers by tumor infiltrating lymphocytes bearing gammadelta(+) t-cell receptors.
    Ferrarini M; Heltai S; Pupa SM; Mernard S; Zocchi R
    J Natl Cancer Inst; 1996 Apr; 88(7):436-41. PubMed ID: 8618235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT.
    Lalaoui N; Morlé A; Mérino D; Jacquemin G; Iessi E; Morizot A; Shirley S; Robert B; Solary E; Garrido C; Micheau O
    PLoS One; 2011; 6(5):e19679. PubMed ID: 21625476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells.
    Shojaei H; Oberg HH; Juricke M; Marischen L; Kunz M; Mundhenke C; Gieseler F; Kabelitz D; Wesch D
    Cancer Res; 2009 Nov; 69(22):8710-7. PubMed ID: 19887600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
    Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
    Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of gammadelta T cell-induced human oligodendrocyte cytotoxicity: relevance to multiple sclerosis.
    Zeine R; Pon R; Ladiwala U; Antel JP; Filion LG; Freedman MS
    J Neuroimmunol; 1998 Jul; 87(1-2):49-61. PubMed ID: 9670845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo.
    Kabelitz D; Wesch D; Pitters E; Zöller M
    J Immunol; 2004 Dec; 173(11):6767-76. PubMed ID: 15557170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective lysis of acute myeloid leukemia cells by CD34/CD3 bispecific antibody through the activation of γδ T-cells.
    Al Agrafi F; Gaballa A; Hahn P; Arruda LCM; Jaramillo AC; Witsen M; Lehmann S; Önfelt B; Uhlin M; Stikvoort A
    Oncoimmunology; 2024; 13(1):2379063. PubMed ID: 39076247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients.
    Gaafar A; Aljurf MD; Al-Sulaiman A; Iqniebi A; Manogaran PS; Mohamed GE; Al-Sayed A; Alzahrani H; Alsharif F; Mohareb F; Ajarim D; Tabakhi A; Al-Hussein K
    Exp Hematol; 2009 Jul; 37(7):838-48. PubMed ID: 19446661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 4,5-diazafluorene derivative on γδ T cell-mediated cytotoxicity against renal cell carcinoma.
    Wen X; Wu Y; Tanaka Y; Awadasseid A; Tao H; Zhang W
    Life Sci; 2021 Mar; 269():119066. PubMed ID: 33460663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tribody [(HER2)
    Oberg HH; Kellner C; Gonnermann D; Sebens S; Bauerschlag D; Gramatzki M; Kabelitz D; Peipp M; Wesch D
    Front Immunol; 2018; 9():814. PubMed ID: 29725336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.